Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02765165 |
| Title | Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Proximagen, LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Washington University | Saint Louis | Missouri | 63110 | United States | Details | |
| University of Oklahoma Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| University of Texas/MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| South Texas Accelerated Research Therapeutics (START) | San Antonio | Texas | 78229 | United States | Details | |
| UT Health San Antonio Cancer Center | San Antonio | Texas | 78229 | United States | Details | |
| South Texas Accelerated Research Therapeutics (START) - FJD | Madrid | Spain | Details |